Literature DB >> 31593765

Genomic characterization of a Klebsiella pneumoniae ST1519 resistant to ceftazidime/avibactam carrying a novel KPC variant (KPC-36).

Paolo Gaibani1, Simone Ambretti2, Caterina Campoli3, PierLuigi Viale3, Maria Carla Re4.   

Abstract

Entities:  

Year:  2019        PMID： 31593765     DOI： 10.1016/j.ijantimicag.2019.09.020

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  3 in total

Review 1.  Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections.

Authors:  Sisi Zhen; Hui Wang; Sizhou Feng
Journal:  Infection       Date:  2022-07-04       Impact factor: 3.553

2.  Increased gene expression and copy number of mutated blaKPC lead to high-level ceftazidime/avibactam resistance in Klebsiella pneumoniae.

Authors:  Lingxiao Sun; Haibo Li; Qi Wang; Yingmei Liu; Bin Cao
Journal:  BMC Microbiol       Date:  2021-08-19       Impact factor: 3.605

3.  Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri.

Authors:  Francois Lebreton; Brendan W Corey; Christi L McElheny; Alina Iovleva; Lan Preston; Katie R Margulieux; Robert J Cybulski; Patrick Mc Gann; Yohei Doi; Jason W Bennett
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.